1. International Diabetes Federation (IDF), Diabetes Atlas 9th edition. Global Fact Sheet. Available at: https://www.diabetesatlas.org/upload/resources/material/20191218_144459_2019_global_factsheet.pdf. Accessed 23 April 2020.
2. Alwin Robert, A., Abdulaziz Al Dawish, M., Braham, R., Ali Musallam, M., Abdullah Al Hayek, A., Hazza Al Kahtany, N. Type 2 diabetes mellitus in Saudi Arabia: major challenges and possible solutions. Curr diabet Rev, 2017;13(1):59-64.
3. Hanssen KF. Blood Glucose Control and Microvascular and Macrovascular Complications in Diabetes. Diabet. 1997;46(2):S101-103.
4. Turner R, Cull C, Frighi V, Holman R. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J Am Med Assoc. 1999;281(21):2005-2012.
5. Riedel A, Heien H, Wogen J, Plauschinat C. Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy. Pharma. 2007;27(8):1102-1110.
6. Lavernia F, Adkins SE, Shubrook JH. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgrad Med J. 2015;127(8):808-817.
7. National Institute for Health and Care Excellence (NICE). Type 1 diabetes in adults: diagnosis and management. 2015. https://pathways.nice.org.uk/pathways/type-1-diabetes-in-adults#path=view%3A/pathways/type-1-diabetes-in-adults/insulin-therapy-for-adults-with-type-1-diabetes.xml&content=view-index. Accessed 01 April 2017.
8. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. 2015. https://www.nice.org.uk/guidance/ng28/chapter/1-recommendations. Accessed 15 March 2018.
9. National Institute for Health and Care Excellence (NICE). Managing blood glucose in adults with type 2 diabetes. 2016. https://pathways.nice.org.uk/pathways/type-2-diabetes-in adults#path=view%3A/pathways/type-2-diabetes-in-adults/managing-blood-glucose-in-adults-with-type-2-diabetes.xml&content=view-node%3Anodes-drug-treatment. Accessed 25 January 2018.
10. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care. 2016;39.
11. Patel A (The ADVANCE Collaborative Group). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. New Eng J Med. 2008;2560-2572.
12. Paul S, Klein K, Thorsted B, Wolden M, Khunti K. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes. Cardiovasc Diab. 2015;14:100.
13. Mata-Cases M, Franch-Nadal J, Real J, Gratacos M, Lopez-Simarro F, Khunti K, Mauricio D. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Fcators predicting intensification of treatment. Diab Obes Metab. 2018;20:103-112.
14. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes 2015: a patient-centered approach. Diabet Care. 2015;38:140-149.
15. Sardar P, Udell JA, Chatterjee S, Bansilal S, Mukherjee D, Farkouh ME. Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials. J Am Hear Assoc. 2015;4(5).
16. Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, Huang ES, Desai MM, Gill TM, Krumholz HM. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116-1124.
17. Umpierrez G, Korytkowski M. Diabetic emergencies-ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev. Endocrin. 2016;12(4):222-232.
18. Naser A, Wong I, Whittlesea C, Beykloo M, Man K, Lau W, Hyassat D & Wei, L. Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan. BMJ. 2018;8:e024909.
19. Berkowitz SA, Aragon K, Hines J, Seligman H, Lee S, Sarkar, U. Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review. Health Serv Res. 2013;48(4):1299-1310.
20. Genere N, Sargis RM, Masi CM, Nathan AG, Quinn MT, Huang ES, Laiteerapong N. Physician perspectives on de-intensifying diabetes medications. Med. 2016;95(46):e5388.
21. Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual of Life Res. 2003;12(3):229-238.
22. Statista. Health and Pharmaceuticals, Physicians, Hospitals and Pharmacies. 2019. https://www.statista.com/statistics/629028/saudi-arabia-number-of-physicians-by-nationality/. Accessed 20 March 2019.
23. Grant RW, Wexler DJ, Watson AJ, Lester WT, Cagliero E, Campbell EG, Nathan DM. How doctors choose medications to treat type 2 diabetes: A national survey of specialists and academic generalists. Diab Car. 2007;30(6):1448-1453.
24. Grant RW, Meigs JB. Quality of diabetes care in U. S. academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337–442.
25. Farmer AKA, Sutton S. Measuring beliefs about taking hypoglycaemic medication among people with type 2 diabetes. Diabetic med: a journal of the British Diabetic Association. 2006;23:265–270.
26. Spoelstra JA, Klungel OH, Erkens JA, Rutten EG, Leufkens HG, Grobbee, DE. Initiation of glucose-lowering therapy in type 2 diabetes mellitus patients in general practice. Diab Med: a journal of the British Diabetic Association. 2008;2:896–900.
27. Zaccardi F, Davies MJ, Dhalwani NN, Webb DR, Housley G, Shaw D et al. Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabet Endocrin, 2016;4(8):677–685.
28. Zhang Q, Marrett E, Jameson K, Meiler S, Davies MJ, Radican L, Sinclair AJ. Reasons given by general practitioners for non-treatment decisions in younger and older patients with newly diagnosed type 2 diabetes mellitus in the United Kingdom: a survey study. BMC endocrin dis, 2011;11(1):17.
29. Daniela V, Pirela, Rajesh G. De-intensification of diabetes treatment in elderly patients with type 2 diabetes mellitus. Endocrin Pract. 2019;25(12):1317-1322.
30. Gerstein H, Miller M, Genuth S, Ismail-Beigi F, Buse JB, Goff DC, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH, Byington P, Rosenberg YDm, Friedewald WT. Long-term effects of intensive glucose lowering on cardiovascular outcomes. The New Eng J of Med. 2011;364:818 – 828.
31. Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med. 2014;174(2):259-268.
32. Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med. 2015;175(3):356-362.
33. Feil DG, Rajan M, Soroka O, Tseng CL, Miller DR, Pogach LM. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: Implications for practice and policy. J of the Am Ger Soc. 2011;59(12):2263-2272.
34. Hall J, Irish J, Roter D. Gender in medical encounters: an analysis of physician and patient communication in a primary care setting. Health Psych. 1994;13:384–392.
35. Tabenkin H, Goodwin M, Zyzanski S, Stange KC, Meadlie JH. Gender differences in time spent during direct observation of doctor-patient encounters. J Wom Health (Larchmt). 2004;13:341–349.
36. Ramirez A, Wildes K, Napoles-Springer A, Perez-Stable E Talavera G, Rios E. Physician gender differences in general and cancer-specific prevention attitudes and practices. J Can Educat. 2009;24:85-93.
37. Tabenkin H, Eaton C, Roberts M, Parker DR, McMurray JH, Borkan J. Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient. Annal Fam Med. 2010;8:25-32.
38. Jefferson L, Bloor K, Hewitt C. The effect of physician gender on length of patient consultations: observational findings from the UK hospital setting and synthesis with existing studies. J Royal Soc Med. 2015;108(4),136-141.
39. Laiteerapong N, John P, Nathan A, Huang ES. Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabet Care. 2013;36:84–89.
40. Seidu S, Kunutsor SK, Topsever P, Hambling CE, Cos FX, Khunti K. Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes. Diabet, Obes Metab, 2019;21(7):1668-1679.
41. Al-Rubeaan KA, Al-Manaa HA, Khoja TA, Al-Sharqawi AH, Aburisheh KH, Youssef AM, Alotaibi MS, Al-Gamdi AA. Health care services provided to type 1 and type 2 diabetic patients in Saudi Arabia. SPJ, 2015;36(10):1216–1225.